A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430
Clinical trial NCT03800173 · COMPLETED
Trial details
- NCT number
- NCT03800173
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2019-04-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.